KSPM
Search
- Page Path
- HOME > Search
Original Articles
- Estimation of Utility Weights for Prostate-related Health States in Korea
- Seon-Ha Kim, Minsu Ock, Min-Woo Jo, Sungchan Park
- J Prev Med Public Health. 2022;55(3):243-252. Published online May 4, 2022
- DOI: https://doi.org/10.3961/jpmph.21.426
- 2,620 View
- 88 Download
-
Abstract
Summary
PDF
Supplementary Material - Objectives
Very limited previous research has investigated the utility weights of prostate-related diseases in the general population in Korea. The purpose of this study was to calculate the utility of prostate-related health states in the Korean general public using the standard gamble (SG) method.
Methods
Seven health states for hypothetical prostate cancers, 1 for benign prostate hyperplasia, and 1 for erectile dysfunction were developed based on patient education material and previous publications. In total, 460 responses from the Korean general population were used to analyze the utility of prostate-related health states. Computer-assisted personal interviews were conducted, and utility values were measured using a visual analogue scale (VAS) and SG. Mean utility values were calculated for each prostate-related health state.
Results
The mean utility values of prostate cancer derived from SG ranged from 0.281 (metastatic castration-refractory prostate cancer) to 0.779 (localized prostate cancer requiring prostatectomy). The utility value of benign prostate hyperplasia was 0.871, and that of erectile dysfunction was 0.812. The utility values obtained using the SG method in all conditions were higher than the values obtained by VAS. There were no significant demographic variables affecting utility values in multivariate analysis.
Conclusions
Our findings might be useful for economic evaluation and utility calculation of screening and interventions for prostate-related conditions in the general population. -
SummaryKorean summary
이 연구는 일반인구집단을 대상으로 7개의 전립선 암 상태와 전립선 비대증, 발기부전상태의 효용값을 표준기회선택법을 이용하여 산출하였다. 전립선암 상태에 따라 평균 효용값은 0.281에서 0.779범위였다. 연구 결과는 전립선 관련 상태의 중재의 효용 계산이나 경제성 평가에 활용할 수 있을 것이다.
- Diabetes Mellitus and Site-specific Colorectal Cancer Risk in Korea: A Case-control Study
- Hyeongtaek Woo, Jeeyoo Lee, Jeonghee Lee, Ji Won Park, Sungchan Park, Jeongseon Kim, Jae Hwan Oh, Aesun Shin
- J Prev Med Public Health. 2016;49(1):45-52. Published online December 22, 2015
- DOI: https://doi.org/10.3961/jpmph.15.029
- 9,641 View
- 159 Download
- 12 Crossref
-
Abstract
PDF
- Objectives
Previous large-scale cohort studies conducted in Korea have found a positive association between diabetes mellitus (DM) and colorectal cancer (CRC) in men only, in contrast to studies of other populations that have found significant associations in both men and women.
Methods
A total of 1070 CRC cases and 2775 controls were recruited from the National Cancer Center, Korea between August 2010 and June 2013. Self-reported DM history and the duration of DM were compared between cases and controls. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated by binary and polytomous logistic regression models.
Results
DM was associated with an elevated risk of CRC in both men (OR, 1.47; 95% CI, 1.13 to 1.90) and women (OR, 1.92; 95% CI, 1.24 to 2.98). This association remained when we controlled for age, body mass index, alcohol consumption, and physical activity level. In sub-site analyses, DM was associated with distal colon cancer risk in both men (multivariate OR, 2.04; 95% CI, 1.39 to 3.00) and women (multivariate ORs, 1.99; 95% CI, 1.05 to 3.79), while DM was only associated with rectal cancer risk in women (multivariate OR, 2.05; 95% CI, 1.10 to 3.82). No significant association was found between DM and proximal colon cancer risk in either men (multivariate OR, 1.45; 95% CI, 0.88 to 2.41) or women (multivariate OR, 1.79; 95% CI, 0.78 to 4.08).
Conclusions
Overall, DM was associated with an increased risk of CRC in Koreans. However, potential over-estimation of the ORs should be considered due to potential biases from the case-control design. -
Summary
Citations
Citations to this article as recorded by
- The interaction between glycemic index, glycemic load, and the genetic variant ADIPOQ T45G (rs2241766) in the risk of colorectal cancer: a case–control study in a Korean population
Y-Thanh Lu, Madhawa Gunathilake, Jeonghee Lee, Jae Hwan Oh, Hee Jin Chang, Dae Kyung Sohn, Aesun Shin, Jeongseon Kim
European Journal of Nutrition.2022; 61(5): 2601. CrossRef - Expression of long non-coding RNA H19 in colorectal cancer patients with type 2 diabetes
Ming Zhao, Hantao Wang, Jingbo Chen, Yang Xi, Fuyan Wang, Cuilan Huo, Wenwen Li, Yudong Chu, Pengjie Xu, Qin Huang, Shizhong Bu
Archives of Physiology and Biochemistry.2021; 127(3): 228. CrossRef - Lymphocyte‐to‐monocyte ratio combined with CA19‐9 for predicting postoperative recurrence of colorectal cancer in patients with diabetes
Dan Yu, Guangyu An, Jiannan Yao
Journal of Clinical Laboratory Analysis.2021;[Epub] CrossRef - Sex- and site-specific differences in colorectal cancer risk among people with type 2 diabetes
Jetty A. Overbeek, Josephina G. Kuiper, Amber A. W. A. van der Heijden, Mariette Labots, Ulrike Haug, Ron M. C. Herings, Giel Nijpels
International Journal of Colorectal Disease.2019; 34(2): 269. CrossRef - Metabolic Syndrome and Risk of Colorectal Cancer: A Case-Control Study
Elham Davtalab Esmaeili, Khairollah Asadollahi, Ali Delpisheh, Kourosh Sayehmiri, Hosein Azizi
International Journal of Cancer Management.2019;[Epub] CrossRef - Colorectal Cancer Risks According to Sex Differences in Patients With Type II Diabetes Mellitus: A Korean Nationwide Population-Based Cohort Study
Ji Min Lee, Kang-Moon Lee, Dae Bum Kim, Seung-Hyun Ko, Yong Gyu Park
Clinical and Translational Gastroenterology.2019; 10(10): e00090. CrossRef - The association between plasma C-peptide concentration and the risk of prostate cancer: a nested case–control study within a Japanese population-based prospective study
Grace Y. Kiyabu, Norie Sawada, Motoki Iwasaki, Taiki Yamaji, Taichi Shimazu, Shizuka Sasazuki, Manami Inoue, Shoichiro Tsugane
European Journal of Cancer Prevention.2018; 27(5): 461. CrossRef - Association between Cardiovascular Risk and Diabetes with Colorectal Neoplasia: A Site-Specific Analysis
David Niederseer, Isabelle Bracher, Andreas Stadlmayr, Ursula Huber-Schönauer, Martin Plöderl, Slayman Obeid, Christian Schmied, Sabrina Hammerl, Felix Stickel, Dieter Lederer, Wolfgang Patsch, Elmar Aigner, Christian Datz
Journal of Clinical Medicine.2018; 7(12): 484. CrossRef - Optimal glycemic target level for colon cancer patients with diabetes
Shin Jun Lee, Jae Hyun Kim, Seun Ja Park, So Young Ock, Su Kyoung Kwon, Young Sik Choi, Bu Kyung Kim
Diabetes Research and Clinical Practice.2017; 124: 66. CrossRef - Impact of detection bias on the risk of gastrointestinal cancer and its subsites in type 2 diabetes mellitus
R.G.P.J. de Jong, A.M. Burden, S. de Kort, M.P.P. van Herk-Sukel, P.A.J. Vissers, P.K.C. Janssen, H.R. Haak, A.A.M. Masclee, F. de Vries, M.L.G. Janssen-Heijnen
European Journal of Cancer.2017; 79: 61. CrossRef - Effects of interactions between common genetic variants and smoking on colorectal cancer
Nan Song, Aesun Shin, Hye Soo Jung, Jae Hwan Oh, Jeongseon Kim
BMC Cancer.2017;[Epub] CrossRef - Diabetes-induced mechanophysiological changes in the small intestine and colon
Mirabella Zhao, Donghua Liao, Jingbo Zhao
World Journal of Diabetes.2017; 8(6): 249. CrossRef
First
Prev
